CorMedix Inc. (CRMD)

CorMedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0.07	0.19	0.24	0.28
Revenue Growth (YoY)	-	-65.74%	-20.19%	-15.55%	-34.09%
Cost of Revenue	0	0	0.15	0.2	0.37
Gross Profit	0	0.06	0.04	0.03	-0.09
Selling, General & Admin	35.8	20.01	16.35	13.88	9.87
Research & Development	13.16	10.68	13.13	13.38	11.05
Operating Expenses	48.96	30.69	29.48	27.26	20.92
Operating Income	-48.96	-30.62	-29.44	-27.22	-21.01
Interest Expense / Income	0.03	0.03	0.02	0.03	0.79
Other Expense / Income	-2.65	-0.36	0.01	-0.06	-0.3
Pretax Income	-46.34	-30.29	-29.46	-27.2	-21.49
Income Tax	0	-0.59	-1.25	-5.17	-5.06
Net Income	-46.34	-29.7	-28.21	-22.03	-16.43
Preferred Dividends	0	0	0	0	27.1
Net Income Common	-46.34	-29.7	-28.21	-22.03	-43.54
Shares Outstanding (Basic)	51	40	38	29	24
Shares Outstanding (Diluted)	51	40	38	29	24
Shares Change	26.39%	6.92%	31.87%	18.26%	35.56%
EPS (Basic)	-0.91	-0.74	-0.75	-0.77	-1.80
EPS (Diluted)	-0.91	-0.74	-0.75	-0.77	-1.80
Free Cash Flow	-38.74	-24.58	-22.58	-22.08	-15.09
Free Cash Flow Per Share	-0.76	-0.61	-0.60	-0.77	-0.63
Gross Margin	-	94.29%	22.00%	14.37%	-31.76%
Operating Margin	-	-46819.91%	-15417.51%	-11378.44%	-7416.31%
Profit Margin	-	-45409.90%	-14774.70%	-9207.70%	-15369.18%
Free Cash Flow Margin	-	-37573.53%	-11826.24%	-9229.69%	-5326.65%
EBITDA	-46.23	-30.18	-29.38	-27.04	-20.63
EBITDA Margin	-	-46135.32%	-15388.71%	-11301.16%	-7283.99%
Depreciation & Amortization	0.07	0.08	0.06	0.13	0.07
EBIT	-46.3	-30.26	-29.44	-27.16	-20.71
EBIT Margin	-	-46264.69%	-15421.12%	-11354.65%	-7309.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).